Coloplast (COLO-B.CO)

Executive Summary

Coloplast is a leading global medical device company focused on intimate healthcare needs, with a strong portfolio in ostomy care, continence care, wound and skin care, and interventional urology. Founded in 1957 and headquartered in Denmark, the company has built a reputation for innovative, user-centric solutions that improve the quality of life for patients. With a market capitalization of approximately $93 billion, Coloplast demonstrates robust financial health and consistent revenue growth, driven by an aging global population, rising prevalence of chronic conditions, and increased awareness of hygiene and quality-of-life products. The company's direct-to-consumer sales model and strong brand loyalty provide a competitive edge in a relatively consolidated market.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation SpeediCath catheter with antimicrobial coating75% success
• Q2 2027FDA approval for new ostomy skin barrier with extended wear80% success
• Q3 2026Acquisition of a wound care startup to expand advanced wound management portfolio60% success